| Literature DB >> 34362428 |
Tao Yang1, Jiangyi Wang2, Junya Cao2, Xinyue Zhang2, Yun Lai1, Longnian Li1, Xiaoying Ye1, Cong You3.
Abstract
BACKGROUND: Staphylococcal Scalded Skin Syndrome (SSSS) is caused by a special type of Staphylococcus aureus (S.aureus) which can produce exfoliative toxins. The generalized SSSS is recommended to be admitted and treated with intravenous antibiotics. However, there were limited reports on whether personal and clinical factors can have impacts on the duration of intravenous antibiotic application for pediatric patients with generalized SSSS. We performed a study to assess the factors affecting intravenous antibiotic treatment course of SSSS patients. Additionally, the positive culture rates of S.aureus in different samples and the antibiotic-resistant profile were investigated.Entities:
Keywords: Antibiotic sensitivity; Intravenous antibiotic treatment; S. aureus; Staphylococcal Scalded Skin Syndrome
Mesh:
Substances:
Year: 2021 PMID: 34362428 PMCID: PMC8344213 DOI: 10.1186/s13052-021-01120-6
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Fig. 1Study flowchart of materials and methods. SSSS: Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus: S. aureus
Baseline characteristic of patients with generalized Staphylococcal Scalded Skin Syndrome
| Characteristics | Cases n(n%)/mean ± SD |
|---|---|
| Gender | |
| Male | 124 (56.62) |
| Female | 95 (43.38) |
| Age (months) | 25.91 ± 17.40 |
| Area | |
| Rural | 149 (68.04) |
| Urban | 70 (31.96) |
| Season | |
| Spring | 26 (11.87) |
| Summer | 76 (34.70) |
| Autumn | 76 (34.70) |
| Winter | 41 (18.72) |
| Tmax(°C) | 37.83 ± 0.78 |
| WBC count(×109/L) | 11.55 ± 4.28 |
| CRP level | |
| Normal | 210 (95.89) |
| Elevated | 9 (4.11) |
| Intravenous antibiotic types | |
| Amoxicillin–clavulanic acid | 32 (14.61) |
| Cefazolin | 117 (53.42) |
| Cefuroxim | 70 (31.96) |
| External antibiotic types | |
| None | 7 (3.20) |
| 2% Mupirocin ointment | 196 (89.50) |
| 2% Fusidic acid cream | 16 (7.31) |
T maximum axillary temperature, WBC white blood cell, CRP C-reactive protein, SD standard deviation
Single factor analysis of variables affecting the intravenous antibiotic treatment course of generalized SSSS
| Characteristics | Group | Days of IV antibiotic treatment (IQR) | |
|---|---|---|---|
| Gender | Male | (6,8) | 0.32 |
| Female | (6,8) | ||
| Area | Rural | (6,8) | 0.52 |
| Urban | (6,8) | ||
| Season | Spring | (6,8) | 0.81 |
| Summer | (6,8) | ||
| Autumn | (6,8) | ||
| Winter | (6,8) | ||
| CRP level | Normal | (6,8) | 0.09 |
| Elevated | (6.5,11) | ||
| IV antibiotic types | Amoxicillin–clavulanic acid | (6,7.75) | 0.46 |
| Cefazolin | (6,8) | ||
| Cefuroxim | (6.75,8) | ||
| External antibiotic application | None | (7,10) | 0.07 |
| 2% Mupirocin ointment | (6,8) | ||
| 2% Fusidic acid cream | (5,7) |
SSSS Staphylococcal Scalded Skin Syndrome, CRP C-reactive protein, IQR (interquartile range), IV intravenous
Fig. 2Simple linear regression analysis of variables affecting the intravenous antibiotic treatment course of generalized SSSS. SSSS: Staphylococcal Scalded Skin Syndrome; Tmax: maximum axillary temperature; WBC: white blood cell; CRP: C-reactive protein
Fig. 3Multiple linear regression analysis of factors affecting the intravenous antibiotic treatment course of generalized SSSS. SSSS: Staphylococcal Scalded Skin Syndrome; WBC: white blood cell; CRP: C-reactive protein
S. aureus detection rates in different sample sources
| Sample source | Positive cases | Negative cases |
|---|---|---|
| Periorificial | 12 (54.55) | 10 (45.45) |
| Blood | 4 (5.97) | 63 (94.03) |
| Throat | 8 (30.77) | 18 (69.23) |
Antibiotic resistance in generalized Staphylococcal Scalded Skin Syndrome-associated S. aureus isolates
| Antibiotics | Sensitive | Resistant | ||
|---|---|---|---|---|
| Levofloxacin | 22 (91.67) | 2 (8.33) | 155.15 | < 0.001 |
| Erythromycin | 0 (0) | 24 (100) | ||
| Gentamycin | 22 (91.67) | 2 (8.33) | ||
| Tetracycline | 18 (75.00) | 6 (25.00) | ||
| TMP/SMX | 4 (16.67) | 20 (83.33) | ||
| Clindamycin | 2 (8.33) | 22 (91.67) | ||
| Oxacillin | 22 (91.67) | 2 (8.33) | ||
| Penicillin G | 0 (0) | 24 (100) | ||
| Vancomycin | 24 (100) | 0 (0) |
TMP/SMX Trimethoprim Sulfamethoxazole,* Pairwise Chi square test comparison showed that the resistant rates of levofloxacin (8.33%), gentamycin (8.33%), tetracycline (25.00%), oxacillin (8.33%), vancomycin (0%) were significantly lower than the ones of erythromycin (100%), TMP/SMX (83.33%), clindamycin (91.67%), penicillin G(100%) (p < 0.001)